Business Description
Aristo Bio-Tech and Lifescience Ltd
ISIN : INE082101010
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | 0.26 | |||||
Debt-to-Equity | 0.62 | |||||
Debt-to-EBITDA | 2.41 | |||||
Interest Coverage | 4.09 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.83 | |||||
Beneish M-Score | 17.33 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.7 | |||||
3-Year EBITDA Growth Rate | 24.8 | |||||
3-Year EPS without NRI Growth Rate | 40.6 | |||||
3-Year FCF Growth Rate | 52.5 | |||||
3-Year Book Growth Rate | 35.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 61.63 | |||||
9-Day RSI | 61.89 | |||||
14-Day RSI | 61 | |||||
6-1 Month Momentum % | 73.9 | |||||
12-1 Month Momentum % | 37.47 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.26 | |||||
Quick Ratio | 0.78 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 54.2 | |||||
Days Sales Outstanding | 88.02 | |||||
Days Payable | 99.4 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.33 | |||||
Dividend Payout Ratio | 0.04 | |||||
Forward Dividend Yield % | 0.33 | |||||
5-Year Yield-on-Cost % | 0.34 | |||||
Shareholder Yield % | 4.43 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 7.93 | |||||
Operating Margin % | 2.82 | |||||
Net Margin % | 1.59 | |||||
FCF Margin % | 0.43 | |||||
ROE % | 12.13 | |||||
ROA % | 3.29 | |||||
ROIC % | 8.92 | |||||
3-Year ROIIC % | 14.52 | |||||
ROC (Joel Greenblatt) % | 14.14 | |||||
ROCE % | 16.86 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 21.07 | |||||
PE Ratio without NRI | 21.07 | |||||
Price-to-Owner-Earnings | 22.35 | |||||
PS Ratio | 0.33 | |||||
PB Ratio | 2.44 | |||||
Price-to-Tangible-Book | 2.44 | |||||
Price-to-Free-Cash-Flow | 78.54 | |||||
Price-to-Operating-Cash-Flow | 10.8 | |||||
EV-to-EBIT | 14.41 | |||||
EV-to-EBITDA | 11.8 | |||||
EV-to-Revenue | 0.41 | |||||
EV-to-FCF | 96.92 | |||||
Price-to-Graham-Number | 1.51 | |||||
Price-to-Net-Current-Asset-Value | 7.24 | |||||
Earnings Yield (Greenblatt) % | 6.94 | |||||
FCF Yield % | 1.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Aristo Bio-Tech and Lifescience Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₹) | 2,451.479 | ||
EPS (TTM) (₹) | 5.72 | ||
Beta | 0 | ||
Volatility % | 56.03 | ||
14-Day RSI | 61 | ||
14-Day ATR (₹) | 7.134157 | ||
20-Day SMA (₹) | 110.1375 | ||
12-1 Month Momentum % | 37.47 | ||
52-Week Range (₹) | 53.1 - 136 | ||
Shares Outstanding (Mil) | 6.81 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Aristo Bio-Tech and Lifescience Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Aristo Bio-Tech and Lifescience Ltd Stock Events
Event | Date | Price(₹) | ||
---|---|---|---|---|
No Event Data |
Aristo Bio-Tech and Lifescience Ltd Frequently Asked Questions
What is Aristo Bio-Tech and Lifescience Ltd(NSE:ARISTO)'s stock price today?
When is next earnings date of Aristo Bio-Tech and Lifescience Ltd(NSE:ARISTO)?
Does Aristo Bio-Tech and Lifescience Ltd(NSE:ARISTO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |